Emilija Vujičić, MD
Resident Physician
Phone021/4805159
She was born on December 21, 1996, completed primary school at "Đorđe Natošević" in Novi Sad (2003–2011). She simultaneously completed primary music school "Josip Slavenski", piano department (2005–2011). She continued her secondary education at the Gymnasium "Jovan Jovanović Zmaj" in Novi Sad (2011–2015). After that, she enrolled in the Faculty of Medicine at the University of Novi Sad, where she completed integrated academic studies in medicine (2015–2021) with an average grade of 9.10, defending her thesis titled "Endometrial Microbiome in Women with Repeated Failed In Vitro Fertilization Procedures". She is currently in the third year of doctoral studies at the Faculty of Medicine in Novi Sad.
| Field | Year of completion | Degree | Faculty | |
|---|---|---|---|---|
| Specialization | Internal Medicine (2025–) | |||
| Faculty | Doctor of Medicine | 2021. | Doctor of Medicine | Faculty of Medicine in Novi Sad |
| Doctorate | Clinical and Experimental Internal Medicine and Oncology (2023–) |
| Training name | Field | Year | Organizer |
|---|---|---|---|
| Diagnosis and Therapy of Sleep Apnea at the Institute for Lung Diseases of Vojvodina | 2026. |
| Year | Title | Publisher | Location |
|---|---|---|---|
| 2025. | Award for Best Poster Presentation | Respiratio | May Pulmonology Days 2025, Trebinje, BIH. |
| Period | Title | Project role |
|---|---|---|
| 2026–ongoing | CTX-791-201 – Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of the oral drug PIPE-791 in subjects with idiopathic pulmonary fibrosis | Study coordinator |
| 2025–ongoing | A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation | Sub-investigator |
IASLC – International Association for the Study of Lung Cancer
MASCC – Multinational Association of Supportive Care in Cancer
ESMO – European Society for Medical Oncology
ERS – European Respiratory Society
EAPC – European Association for Palliative Care
UMOS – Association of Medical Oncologists of Serbia
SLD – Serbian Medical Society, Section of Palliative Medicine (president of the section), Regional Medical Chamber of Vojvodina
UBS – Association of Bronchologists of Serbia
DLS – Section of Palliative Medicine of Serbia, Society of Physicians of Serbia
RUS – Respiratory Association of Serbia
CUMO – Montenegrin Association of Medical Oncologists
Vujičić E, Ilić M, Kovačević D, Javorac J, Savić N, Kovač M, Živanović D, Miljković D. Hypersensitivity pneumonitis – experiences in treatment so far and opening up new possibilities. Serbian Archives of Medicine. 2025(00):63-.
Vujičić E, Kovačević D, Ilić M, Javorac J, Jovanović S, Savić N, Tot Vereš K, Galić M, Đekić D, Šojić A, Krajnović B. Silicosis. In: Respiratio. May 2025;15(1-2):156-65.
Vujičić E, Ilić M, Kovačević D, Miljković D, Javorac J, Savić N, Đekić D. Pulmonary alveolar proteinosis in Vojvodina – in light of new recommendations. MD-Medical Data. 2025;17(1):51-6.
Vujičić E, Ilić M, Bjelajac D, Kuhajda I, Kašiković-Lečić S, Kukavica D, Jovanović S, Savić N, Tot Vereš K, Kovačević D, Javorac J, Mršić B, Đekić D, Radić A. Concurrent occurrence of usual interstitial pneumonia and bronchial carcinoma. In: Respiratio. May 2024;14(1-2):320-6.
5. Vujičić E, Ilić M, Kašiković-Lečić S, Kovačević D, Đekić D, Savić N, Kukavica D, Javorac J, Milenković A, Lovrenski A. Bone marrow sarcoidosis – a clinical diagnostic challenge: case report. In: Abstract book of the 8th Congress of Serbian Respiratory Medicine with International Participation; 2025 September 19-21; Belgrade, Serbia; Belgrade: MEDAPP Association; 2025. p.80.
Vujičić E, Ilić M, Kukavica D, Kovačević D, Javorac J, Savić N, Kašiković-Lečić S, Đekić D, Lovrenski A, Tot Vereš K, Radić A. Association of "sarcoid-like" granuloma and squamous cell lung carcinoma – case report. In: Respiratio. May 2023;13(1-2):429-34.
Vujičić E, Ilić M, Kukavica D, Kašiković Lečić S, Kovačević D, Javorac J. Endobronchial tuberculosis: case report (abstract). In: Abstract book of the 7th Congress of Serbian Respiratory Medicine with International Participation; 2023 April 20-23; Vrnjačka Banja, Serbia; Belgrade: MEDAPP Association; 2023. p.146.
8. Kovačević D, Ilić M, Vujičić E, Miljković D, Javorac J, Stjepanović M, et al. A decade of challenges: ten-year analysis of non-tuberculous Mycobacteria infections in Vojvodina, Serbia. J Infect Dev Ctries. 19:1503–1507.
Ilić M, Javorac J, Milenković A, Živanović D, Miljković D, Kašiković Lečić S, Savić N, Tot Vereš K, Kovačević D, Vujičić E, Kopitović I. Home-Based Spirometry in Patients with Interstitial Lung Diseases: A Real-Life Pilot “FACT” Study from Serbia. Journal of Personalized Medicine. 2023;13(5):793.
Javorac J, Živanović D, Ilić M, Milenković A, Vujičić E, Kovačević D, Zvekić-Svorcan J, Mikić D, Stojkov S, Bačevac Eminović J, Jevtić M. Air Pollution and COPD: Unveiling Hidden Risks of Mortality, Mechanical Ventilation, and Prolonged Hospitalization. Atmosphere. 2025;16(1):36.
| Year | Title | Location | Role | Lecture/session title |
|---|---|---|---|---|
| XIII Academy of Respiratory Medicine of Serbia | Niš, Serbia | lecturer | Systemic Sclerosis and Pulmonary Manifestations | |
| 2025. | May Pulmonology Days | Trebinje, BIH | lecturer | Pulmonary Silicosis |
| 2024. | May Pulmonology Days | Teslić, BIH | lecturer | Concurrent Occurrence of Usual Interstitial Pneumonia and Bronchial Carcinoma |